OKT3 AND CMV DISEASE IN CADAVERIC RENAL-TRANSPLANT RECIPIENTS

被引：0
|
作者：
JOSEPHSON, M
THISTLETHWAITE, JR
STUART, J
STUART, FP
机构：
[1] UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637
[2] UNIV CHICAGO,DEPT SURG,CHICAGO,IL 60637
来源：
KIDNEY INTERNATIONAL | 1990年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [41] A PROSPECTIVE CLINICAL-TRIAL COMPARING LOW-DOSE OKT3 PROPHYLAXIS AND PREDNISOLONE CYCLOSPORINE TREATMENT IN RENAL-TRANSPLANT RECIPIENTS
    PARLEVLIET, KJ
    TENBERGE, IJM
    WILMINK, JM
    SURACHNO, J
    SCHELLEKENS, PTA
    KIDNEY INTERNATIONAL, 1993, 43 (04) : 971 - 972
  • [42] IDENTIFICATION AND FUNCTION OF A MAJOR OKT3, OKT8, LEU-7, POSITIVE LYMPHOCYTE SUBPOPULATION IN RENAL-TRANSPLANT RECIPIENTS TREATED WITH TOTAL LYMPHOID IRRADIATION
    WAER, M
    VANRENTERGHEM, Y
    VANDERSCHUEREN, E
    MICHIELSEN, P
    VANDEPUTTE, M
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1570 - 1571
  • [43] Severe thrombocytopenia with OKT3 use for steroid-resistant rejection in a cadaveric renal transplant recipient
    Mackie, F
    Verran, D
    Horvath, J
    Tiller, D
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (11) : 2378 - 2378
  • [44] PROPHYLACTIC OKT3 AND CADAVERIC RENAL-TRANSPLANTATION AT A SINGLE CENTER
    SHIELD, CF
    HUGHES, JD
    LEMON, JA
    CLINICAL TRANSPLANTATION, 1988, 2 (04) : 190 - 193
  • [45] PROSPECTIVE RANDOMIZED TRIAL OF EFFICACY OF GANCICLOVIR VERSUS THAT OF ANTICYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN TO PREVENT CMV DISEASE IN CMV-SEROPOSITIVE HEART-TRANSPLANT RECIPIENTS TREATED WITH OKT3
    AGUADO, JM
    GOMEZSANCHEZ, MA
    LUMBRERAS, C
    DELGADO, J
    LIZASOAIN, M
    OTERO, JR
    RUFILANCHAS, JJ
    NORIEGA, AR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1643 - 1645
  • [46] Improved outcome in renal transplant recipients treated with simulect versus OKT3 induction.
    Pelletier, RP
    Davies, EA
    Elkhammas, EA
    Bumgardner, GL
    Henry, ML
    Ferguson, RM
    TRANSPLANTATION, 2000, 69 (08) : S157 - S157
  • [47] LOW-DOSE OKT3 FOR CADAVERIC RENAL-TRANSPLANTATION
    SCHWEIZER, RT
    ROPER, L
    HULL, D
    BARTUS, SA
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (06) : 2592 - 2593
  • [48] OKT3 induction therapy and cadaveric renal transplantation in black patients
    Reinitz, ER
    Kaplan, MP
    Sillix, DH
    Lysz, K
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (08) : 3703 - 3705
  • [49] EFFECTS OF CYTOMEGALOVIRUS (CMV) INFECTION IN YOUNG RENAL-TRANSPLANT RECIPIENTS
    MARKER, SC
    HOWARD, RJ
    SIMMONS, RL
    SIEKERT, RG
    CONNELLY, DP
    NAJARIAN, JS
    BALFOUR, HH
    PEDIATRIC RESEARCH, 1979, 13 (04) : 464 - 464
  • [50] DIFFUSE ANTERIOR SCLERITIS DURING OKT3 MONOCLONAL-ANTIBODY THERAPY FOR RENAL-TRANSPLANT REJECTION
    MCCARTHY, JM
    SULLIVAN, K
    KEOWN, PA
    ROLLINS, DT
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1992, 27 (01): : 22 - 24
12345